NRIX
Nurix Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$25.44
−0.24%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 34.03x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.56x
- Price / sales
- 71.81x
- Price / cash flow
- -8.99x
Enterprise value
- Enterprise value
- $2.3B
- EV / sales
- 61.33x
- EV / EBITDA
- -7.05x
- EV / EBIT
- -6.24x
- Market cap
- $2.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of May 1, 2026